Cimicoxib
Cimicoxib Uses, Dosage, Side Effects, Food Interaction and all others data.
Cimicoxib is a selective COX-2 inhibitor being developed by Affectis as a treatment for depression and schizophrenia. If approved, Cimicoxib would be the first drug in decades to treat depression by a new mechanism of action.
Trade Name | Cimicoxib |
Generic | Cimicoxib |
Cimicoxib Other Names | Cimicoxib |
Type | |
Formula | C16H13ClFN3O3S |
Weight | Average: 381.809 Monoisotopic: 381.035017899 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
Investigated for use/treatment in depression.
How Cimicoxib works
Depression and schizophrenia are inflammatory diseases. Increased levels of pro-inflammatory cytokines and prostaglandin E (PGE) have repeatedly been described in major depression. COX-2 inhibitors inhibit production of both. Cimicoxib is a selective COX-2 inhibitor. The mechanism by which some COX-2 inhibitors work in depression could be linked to their anti-inflammatory mechanisms.
Innovators Monograph
You find simplified version here Cimicoxib